Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
Ami M. Kabadi(Sarepta Therapeutics (United States)), Charles A. Gersbach(Duke University), Isaac B. Hilton(Rice University), David G. Ousterout(Profectus Biosciences (United States))
Cited by 388
Related Papers
RNA-guided gene activation by CRISPR-Cas9–based transcription factors
|Nature Methods|2013|1.3k
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
|Science|2015|1.1k
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy
|Nature Communications|2015|456
Synergistic and tunable human gene activation by combinations of synthetic transcription factors
|Nature Methods|2013|241